Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07533955
PHASE1

A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis

Sponsor: Jade Biosciences, Inc.

View on ClinicalTrials.gov

Summary

This is a Phase 1, first in human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE201 compared to placebo in participants with Rheumatoid Arthritis

Official title: A Phase 1, Randomized, Double-blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JADE201 Administered Subcutaneously in Participants With Rheumatoid Arthritis

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2026-05

Completion Date

2028-10

Last Updated

2026-04-21

Healthy Volunteers

No

Interventions

DRUG

JADE201

JADE201 is supplied as sterile solution to be administered by SC injection.

DRUG

Placebo

Placebo solution to be administered at a matching volume by SC injection.

Locations (3)

Jade Clinical Site

Chisinau, Moldova, Moldova

Jade Clinical Site

Ivano-Frankivsk, Ukraine, Ukraine

Jade Clinical Site

Kyiv, Ukraine, Ukraine